Firm launches study of mitral regurgitation device

01/16/2013 | MassDevice.com (Boston)

Phoenix Cardiac Devices has begun patient enrollment in a clinical study of its Bace system, which is used to treat mitral regurgitation without the need for open-heart procedures. The trial, which will involve 60 patients from Europe and India, will be used to help the company obtain CE mark approval for the device in Europe.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI